Compare Stocks

Date Range: 

 BetterLife PharmaTeligentTower One WirelessiCo TherapeuticsAcerus Pharmaceuticals
Price Information
Current Price$0.54$0.54N/A$0.08$0.04
52 Week RangeN/AHoldN/AN/AN/A
Overall Score0.
Analysis Score0.
Community Score0.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationN/AHoldN/AN/AN/A
Consensus Price TargetN/A$2.00N/AN/AN/A
% Upside from Price TargetN/A270.37% upsideN/AN/AN/A
Trade Information
Market Cap$9.29 million$11.84 million$9.19 million$11.99 million$11.17 million
Average Volume79,2505,614,751116,944139,3585,474
Sales & Book Value
Annual RevenueN/A$65.90 million$4.08 millionN/A$7.38 million
Price / SalesN/A0.180.00N/A1.51
Price / CashN/AN/AN/AN/AN/A
Book Value$0.12 per share($0.99) per share($0.07) per shareN/AN/A
Price / BookN/A-0.550.00N/A
Net Income$-14,780,000.00$-25,120,000.00$-3,750,000.00$-1,460,000.00$-18,790,000.00
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/A
Net MarginsN/A-91.50%N/AN/A-254.66%
Return on Equity (ROE)-734.15%N/AN/A-472.87%-346.72%
Return on Assets (ROA)-219.66%-17.52%-39.36%-177.94%-94.54%
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/AN/AN/AN/A0.64%
Current Ratio0.16%2.48%0.08%0.58%1.35%
Quick Ratio0.16%1.25%0.08%0.58%0.90%
Ownership Information
Institutional Ownership PercentageN/A28.15%N/AN/A0.02%
Insider Ownership Percentage34.77%2.09%N/AN/AN/A
Shares Outstanding17.21 million21.75 million93.34 million153.75 million258.62 million
Next Earnings Date7/5/2021 (Estimated)5/28/2021 (Estimated)7/13/2021 (Estimated)7/12/2021 (Estimated)N/A
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
8/20/2020TeligentCraig HallumDowngrade
10/3/2019TeligentRaymond JamesDowngrade
11/16/2018TeligentCanaccord GenuityLower Price Target
(Data available from 5/5/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.